PCOL Flashcards
(300 cards)
Mechanism of action of local anesthetics.
A. Block sodium channel thereby stopping
axonal conduction
B. Block alpha and beta receptor
C. Block neuronal firing by decreasing Ach
in the neuromuscular junction
D. Inhibition of acetyl cholinesterase
enzyme
E. Inhibition of enzyme responsible for pain response
A. Block sodium channel thereby stopping
axonal conduction
The following are factors that affect the
absorption of drug from the gastrointestinal (GI) track except:
A. Surface area of absorption
B. Blood flow to the site of absorption
C. Physical state of the drug
D. Concentration of the drug at the site of absorption
E. Protein binding
E. Protein binding
Continued stimulation of cells with agonists generally results in which of the following?
A. Desensitization
B. Up-regulation
C. Down-regulation
Desensitization
Down-regulation
Drug that lacks intrinsic efficacy but retains affinity and competes with the agonist for the binding sites of the receptor.
A. Competitive antagonist
B. Full agonist
C. Non-competitive antagonist
D. Partial antagonist
E. Partial agonist
A. Competitive antagonist
This type of drug produce its effect by binding a site on the receptor distinct from that of the primary agonist and thereby changing the affinity of the receptor for the agonist.
A. Competitive antagonist
B. Full agonist
C. Non-competitive antagonist
D. Partial antagonist
E. Partial agonist
C. Non-competitive antagonist
In this type of study, participants are blinded to treatment assignment, investigators are not.
A. Double blind study
B. Single blind study
C. Masking
D. Open-label
E. Un-blinded study
B. Single blind study
The neurotransmitter of all preganglionic autonomic fibers, and all postganglionic parasympathetic fibers:
A. Norepinephrine
B. Noradrenaline
C. Acetylcholine
D. A and B
E. A and C
C. Acetylcholine
The release of ach and other neurotransmitters by exocytosis is inhibited by:
A. Acetylcholinesterase
B. Botulinum toxin
C. Reserpine
D. Metyrosine
E. Guanethidine
B. Botulinum toxin
All of the following are enzymes involved in the biosynthesis of epinephrine from tyrosine EXCEPT:
A. Tyrosine hydroxylase
B. Aromatic L amino acid decarboxylase
C. Dopamine Beta-hydroxylase
D. Phenyl ethanolamine-N-Methyl transferase
E. Monoamine oxidase
E. Monoamine oxidase
Rate limiting enzyme in the synthesis of catecholamines:
A. Tyrosine hydroxylase
B. Aromatic L-amino acid decarboxylase
C. Dopamine beta-hydroxylase
D. Phenyl ethanolamine-N-Methyl transferase
E. COMT
A. Tyrosine hydroxylase
All of the following are effects of activating beta 2 receptor, EXCEPT:
A. Bronchoconstriction
B. Uterine Relaxation
C. Glycogenolysis
D. Gluconeogenesis
E. Bronchodilation
A. Bronchoconstriction
All of the following are effects of activating alpha 1 receptor EXCEPT:
A. Vascular smooth muscle relaxation
B. Intestinal smooth muscle relaxation
C. Increase contractive force of the heart
D. Glycogenolysis in the liver
E. Vascular smooth muscle constriction
A. Vascular smooth muscle relaxation
Which of the following is a pharmacological effect of muscarinic stimulation in the cardiovascular system?
A. Vasoconstriction
B. Decrease in cardiac rate
C. Positive chronotropic effect
D. Positive dromotropic effect
E. Positive inotropic effect
B. Decrease in cardiac rate
All of the following are naturally occurring
chromonematic Alkaid, EXCEPT:
A. Pilocarpine
B. Muscarine
C. Acetylcholine
D. Arecoline
E. None of these
C. Acetylcholine
Which of the following is/are effects of cholinomimetic drugs?
I. Stimulation of GI smooth muscle
II. Stimulation of secretion of exocrine gland
III. Bronchoconstriction
IV. Tachycardia
A. I and II
B. II and III
C. I, II and III
D. I and IV
E. I, II, III and IV
C. I, II and III
Major contraindication to the use of muscarinic agonist are the following EXCEPT:
A. Asthma
B. Hypothyroidism
C. Coronary insufficiency
D. Acid-peptic disease
E. Hypertension
E. Hypertension
Used in the treatment of glaucoma where it is instilled into the eye usually as a 0.5-4% solution.
A. Epinephrine
B. Eye-Mo®
C. Pilocarpine
D. Bethanecol
E. Atropine
C. Pilocarpine
Most effective prophylactic agent for short (4-6 hours) exposure to severe motion, also available as transdermal patch.
A. Atropine
B. Scopolamine
C. Ipratropium
D. Tiotropium
E. Varenicline
B. Scopolamine
Which of the following drugs is/are classified an acetylcholinesterase inhibitor?
I. Pilocarpine
II. Edrophonium
III. Tacrine
IV. Atropine
A. I only
B. I and II
C. II and III
D. I, II and III
E. IV only
C. II and III
Which of the following is not an effect of anti-cholinesterase agents?
A. Stimulation of muscarinic receptor responses at autonomic effector organs
B. Stimulation, followed by depression or paralysis of all autonomic ganglia and skeletal muscle
C. Stimulation, with occasional subsequent depression of cholinergic receptor sites in the CNS
D. All of these
E. None of these
E. None of these
Intoxication with an organophosphorus anticholinesterase agent can be treated with:
A. Atropine
B. Pralidoxime
C. Malathion
D. A and B
E. B and C
D. A and B
This agent is used in the diagnosis of myasthenia gravis
A. Edrophonium
B. Atropine
C. Neostigmine
D. Pralidoxime
E. Acetylcholine
A. Edrophonium
All are standard anticholinesterase drugs used in the symptomatic treatment of myasthenia gravis, EXCEPT:
A. Pyridostigmine
B. Neostigmine
C. Atropine
D. Ambenonium
E. Edrophonium
C. Atropine
Mechanism of action of indirect acting sympathomimetics drugs:
A. Agents act directly on one or more of the adrenergic receptors thereby producing an effect
B. Increase the availability of norepinephrine (NE) or epinephrine (Epi) to stimulate adrenergic receptors
C. Releasing or displacing NE from sympathetic nerve varicosities
D. A and B
E. B and C
E. B and C